MAIA Biotechnology (MAIA) Projected to Post Quarterly Earnings on Tuesday

MAIA Biotechnology (NYSEAMERICAN:MAIA - Get Free Report) is expected to be releasing its Q1 2025 earnings data before the market opens on Tuesday, May 13th. Analysts expect the company to announce earnings of ($0.18) per share for the quarter.

MAIA Biotechnology Price Performance

NYSEAMERICAN:MAIA traded up $0.09 during trading hours on Tuesday, reaching $2.00. 94,252 shares of the company were exchanged, compared to its average volume of 236,252. The business has a 50 day moving average of $1.72 and a 200 day moving average of $2.14. MAIA Biotechnology has a 1-year low of $1.40 and a 1-year high of $5.99. The company has a market capitalization of $52.19 million, a P/E ratio of -1.45 and a beta of 0.20.

MAIA Biotechnology Company Profile

MAIA Biotechnology, Inc, a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.